TGF-β1-induced EMT activation via both Smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis

Hongrui Guo,Zhijie Jian,Huan Liu,Hengmin Cui,Huidan Deng,Jing Fang,Zhicai Zuo,Xun Wang,Ling Zhao,Yi Geng,Ping Ouyang,Huaqiao Tang
DOI: https://doi.org/10.1016/j.taap.2021.115500
IF: 4.46
2021-05-01
Toxicology and Applied Pharmacology
Abstract:<p>Copper (Cu) is considered as an essential trace element for living organisms. However, over-exposure to Cu can lead to adverse health effects on human and animals. There are limited researches on pulmonary toxicity induced by Cu. Here, we found that copper sulfate (CuSO<sub>4</sub>)-treatment could induce pulmonary fibrosis with Masson staining and up-regulated protein and mRNA expression of Collagen I and α-Smooth Muscle Actin (α-SMA) in mice. Next, the mechanism underlying Cu-induced pulmonary fibrosis was explored, including transforming growth factor-β1 (TGF-β1)-mediated Smad pathway, mitogen-activated protein kinases (MAPKs) pathway and epithelial-mesenchymal transition (EMT). CuSO<sub>4</sub> triggered pulmonary fibrosis by activation of the TGF-β1/Smad pathway, which was accomplished by increasing TGF-β1, p-Smad2 and p-Smad3 protein and mRNA expression levels. Also, up-regulated protein and mRNA expression of p-JNK, p-ERK, and p-p38 demonstrated that CuSO<sub>4</sub> activated MAPKs pathways. Concurrently, EMT was activated by increasing vimentin and N-cadherin while decreasing E-cadherin protein and mRNA expression levels. Altogether, the abovementioned findings indicate that CuSO<sub>4</sub> treatment may induce pulmonary fibrosis through the activation of EMT induced by TGF-β1/Smad pathway and MAPKs pathways, revealing the mechanism Cu-caused pulmonary toxicity.</p>
pharmacology & pharmacy,toxicology
What problem does this paper attempt to address?